{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:29:30Z","timestamp":1785475770810,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.vaccine.2005.01.147","type":"journal-article","created":{"date-parts":[[2005,2,22]],"date-time":"2005-02-22T13:09:33Z","timestamp":1109077773000},"page":"3535-3544","source":"Crossref","is-referenced-by-count":30,"title":["Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection"],"prefix":"10.1016","volume":"23","author":[{"given":"Jianmin","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieh-Juen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry T.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.01.147_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13693780410001687349","article-title":"A vaccine against coccidioidomycosis is justified and attainable","volume":"42","author":"Cole","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2005.01.147_bib2","series-title":"Fungal pathogenesis: principles and applications","first-page":"365","article-title":"Coccidioidomycosis: pathogenesis, immune response and vaccine development","author":"Kirkland","year":"2002"},{"issue":"5","key":"10.1016\/j.vaccine.2005.01.147_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3201\/eid0705.010505","article-title":"Cost-effectiveness of a potential vaccine for Coccidioides immitis","volume":"7","author":"Barnato","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2005.01.147_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0923-2494(98)80765-7","article-title":"Protective immunity in coccidioidomycosis","volume":"149","author":"Cox","year":"1998","journal-title":"Res Immunol"},{"key":"10.1016\/j.vaccine.2005.01.147_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.1956.02960420026008","article-title":"Patterns of 39,500 serologic tests in coccidioidomycosis","volume":"160","author":"Smith","year":"1956","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2005.01.147_bib6","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/IAI.71.6.3010-3019.2003","article-title":"A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis","volume":"71","author":"Delgado","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2005.01.147_bib7","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/IAI.69.5.2878-2887.2001","article-title":"Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice","volume":"69","author":"Li","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2005.01.147_bib8","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1128\/IAI.70.6.3287-3289.2002","article-title":"Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2\/PRA","volume":"70","author":"Shubitz","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2005.01.147_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Martin","year":"1998","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2005.01.147_bib10","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/IAI.69.3.1554-1560.2001","article-title":"Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus","volume":"69","author":"Brieland","year":"2001","journal-title":"Infect Immun"},{"issue":"8 Pt 1","key":"10.1016\/j.vaccine.2005.01.147_bib11","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.150.8.3602","article-title":"Patterns of cytokine gene expression by CD4+ T cells from young and old mice","volume":"150","author":"Hobbs","year":"1993","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.01.147_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1078\/0344-0338-00440","article-title":"Laser-controlled microdissection of tissues opens a window of new opportunities","volume":"199","author":"Hergenhahn","year":"2003","journal-title":"Pathol Res Pract"},{"issue":"7","key":"10.1016\/j.vaccine.2005.01.147_bib13","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1128\/JCM.41.7.3419-3422.2003","article-title":"Evaluation of fungal burden in experimental paracoccidioidomycosis by using the fluorescent dye Blankophor","volume":"41","author":"Nishikaku","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.01.147_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9440(10)64749-9","article-title":"Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection","volume":"156","author":"Simone","year":"2000","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.01.147_bib15","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.164.5.2619","article-title":"Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo","volume":"164","author":"Radoja","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.01.147_bib16","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/IAI.72.5.2679-2688.2004","article-title":"Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses","volume":"72","author":"Rial","year":"2004","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2005.01.147_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.189.3.553","article-title":"Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice","volume":"189","author":"Korsgren","year":"1999","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2005.01.147_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/IAI.21.3.862-865.1978","article-title":"Chemotaxigenic activity of extracts from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes","volume":"21","author":"Galgiani","year":"1978","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.01.147_bib19","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/IAI.71.8.4225-4228.2003","article-title":"Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle","volume":"71","author":"Casadevall","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2005.01.147_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.0902-0055.2002.00098.x","article-title":"Differences in mouse strain influence leukocyte and immunoglobulin phenotype response to Porphyromonas gingivalis","volume":"18","author":"Gemmell","year":"2003","journal-title":"Oral Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.01.147_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","article-title":"Type 1\/Type 2 immunity in infectious diseases","volume":"32","author":"Spellberg","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2005.01.147_bib22","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1128\/IAI.64.9.3609-3613.1996","article-title":"Interleukin-12 regulation of host defenses against Coccidioides immitis","volume":"64","author":"Magee","year":"1996","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.01.147_bib23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/IAI.66.4.1473-1481.1998","article-title":"Evolution of the primary immune response to Histoplasma capsulatum in murine lung","volume":"66","author":"Cain","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.01.147_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1471-4914(02)02302-X","article-title":"Interleukin-5 and eosinophils as therapeutic targets for asthma","volume":"8","author":"Foster","year":"2002","journal-title":"Trends Mol Med"},{"issue":"12","key":"10.1016\/j.vaccine.2005.01.147_bib25","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1128\/IAI.70.12.6940-6947.2002","article-title":"Contribution of interleukin-12 (IL-12) and the CD28\/B7 and CD40\/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice","volume":"70","author":"Wille","year":"2002","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2005.01.147_bib26","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1128\/IAI.66.9.4397-4402.1998","article-title":"Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis","volume":"66","author":"Fierer","year":"1998","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2005.01.147_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4049\/jimmunol.163.3.1205","article-title":"Peptide dose, affinity, and time of differentiation can contribute to the Th1\/Th2 cytokine balance","volume":"163","author":"Rogers","year":"1999","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.01.147_bib28","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4049\/jimmunol.170.3.1218","article-title":"Differential antigen sensitivity and costimulatory requirements in human Th1 and Th2 antigen-specific CD4+ cells with similar TCR avidity","volume":"170","author":"Holzer","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.01.147_bib29","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.164.6.2955","article-title":"CD28, Ox-40, LFA-1, and CD4 modulation of Th1\/Th2 differentiation is directly dependent on the dose of antigen","volume":"164","author":"Rogers","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.01.147_bib30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/IAI.68.2.584-593.2000","article-title":"A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses","volume":"68","author":"Hung","year":"2000","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.01.147_bib31","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1128\/IAI.65.8.3376-3380.1997","article-title":"Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes","volume":"65","author":"Zhu","year":"1997","journal-title":"Infect Immun"},{"issue":"13","key":"10.1016\/j.vaccine.2005.01.147_bib32","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S1286-4579(02)00007-2","article-title":"Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants","volume":"4","author":"Bozza","year":"2002","journal-title":"Microb Infect\/Institut Pasteur"},{"issue":"9","key":"10.1016\/j.vaccine.2005.01.147_bib33","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1128\/IAI.71.9.5121-5129.2003","article-title":"Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability","volume":"71","author":"Mendez","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.01.147_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.01.147_bib35","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.96.12.6970","article-title":"Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms","volume":"96","author":"Walker","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2005.01.147_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nm987","article-title":"Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration","volume":"10","author":"Heikenwalder","year":"2004","journal-title":"Nature Med"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2005.01.147_bib37","first-page":"3503","article-title":"Third meeting on novel adjuvants currently in or close to clinical testing. World Health Organization, Merieux Foundation, Annecy, France, January 7\u20139, 2002","volume":"21","author":"Engers","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2005.01.147_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm0703-831","article-title":"CpG motifs: the active ingredient in bacterial extracts?","volume":"9","author":"Krieg","year":"2003","journal-title":"Nature Med"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2005.01.147_bib39","first-page":"1533","article-title":"Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3","volume":"85","author":"Hong","year":"2004","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.01.147_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14760584.2.2.239","article-title":"Development of a leishmaniasis vaccine: the importance of MPL","volume":"2","author":"Reed","year":"2003","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05002513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05002513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T07:51:17Z","timestamp":1683013877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05002513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":40,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0264410X05002513"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.147","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}